一种针对心脏代谢疾病的新型综合征方法的重要性。 - Suppr

Suppr

超能文献

The Importance of a Novel Syndemic Approach for Cardiometabolic Diseases.

作者信息

Rizzo Manfredi

机构信息

School of Medicine, Promise Department, University of Palermo, Palermo, Italy.

出版信息

Curr Med Chem. 2024;31(18):2483-2485. doi: 10.2174/0929867331666230918114009.

DOI:10.2174/0929867331666230918114009

PMID:37723636

Abstract

摘要

相似文献

The Importance of a Novel Syndemic Approach for Cardiometabolic Diseases.

Curr Med Chem. 2024;31(18):2483-2485. doi: 10.2174/0929867331666230918114009.

Editorial: Molecular biomarkers of cardiometabolic disease.

Front Endocrinol (Lausanne). 2024 Aug 12;15:1471571. doi: 10.3389/fendo.2024.1471571. eCollection 2024.

Emerging therapeutic potential of glycine in cardiometabolic diseases: dual benefits in lipid and glucose metabolism.

Curr Opin Lipidol. 2018 Oct;29(5):428-432. doi: 10.1097/MOL.0000000000000543.

New lipid and lipoprotein targets for the treatment of cardiometabolic diseases.

J Lipid Res. 2012 Sep;53(9):1719-21. doi: 10.1194/jlr.E030205. Epub 2012 Jul 5.

Targeting Apelinergic System in Cardiometabolic Disease.

Curr Drug Targets. 2017;18(15):1785-1791. doi: 10.2174/1389450117666160613105152.

Targeting Interferon Regulatory Factor for Cardiometabolic Diseases: Opportunities and Challenges.

Curr Drug Targets. 2017;18(15):1754-1778. doi: 10.2174/1389450116666150804110412.

Metabolic syndrome and cardiometabolic risk in PCOS.

Curr Diab Rep. 2007 Feb;7(1):66-73. doi: 10.1007/s11892-007-0012-8.

Adrenomedullin 2/intermedin: a putative drug candidate for treatment of cardiometabolic diseases.

Br J Pharmacol. 2018 Apr;175(8):1230-1240. doi: 10.1111/bph.13814. Epub 2017 May 16.

Promoting a Syndemic Approach for Cardiometabolic Disease Management During COVID-19: The CAPISCO International Expert Panel.

Front Cardiovasc Med. 2021 Dec 15;8:787761. doi: 10.3389/fcvm.2021.787761. eCollection 2021.

Insight from mitochondrial functions and proteomics to understand cardiometabolic disorders in survivors of acute lymphoblastic leukemia.

Metabolism. 2018 Aug;85:151-160. doi: 10.1016/j.metabol.2018.03.011. Epub 2018 Mar 18.

本文引用的文献

Glucometabolic Perturbations in Type 2 Diabetes Mellitus and Coronavirus Disease 2019: Causes, Consequences, and How to Counter Them Using Novel Antidiabetic Drugs - The CAPISCO International Expert Panel.

Exp Clin Endocrinol Diabetes. 2023 May;131(5):260-267. doi: 10.1055/a-2019-1111. Epub 2023 Jan 24.

Centering Patient Voices Through Community Engagement in Cardiovascular Research.

Circulation. 2023 Jan 10;147(2):105-107. doi: 10.1161/CIRCULATIONAHA.122.061112. Epub 2023 Jan 9.

Post-COVID syndrome, inflammation, and diabetes.

J Diabetes Complications. 2022 Nov;36(11):108336. doi: 10.1016/j.jdiacomp.2022.108336. Epub 2022 Oct 6.

Molecular and pro-inflammatory aspects of COVID-19: The impact on cardiometabolic health.

Biochim Biophys Acta Mol Basis Dis. 2022 Dec 1;1868(12):166559. doi: 10.1016/j.bbadis.2022.166559. Epub 2022 Sep 26.

The Dual Pandemics of COVID-19 and Obesity: Bidirectional Impact.

Diabetes Ther. 2022 Oct;13(10):1723-1736. doi: 10.1007/s13300-022-01311-2. Epub 2022 Aug 27.

Association between use of novel glucose-lowering drugs and COVID-19 hospitalization and death in patients with type 2 diabetes: a nationwide registry analysis.

Eur Heart J Cardiovasc Pharmacother. 2022 Dec 15;9(1):10-17. doi: 10.1093/ehjcvp/pvac044.

Promoting a Syndemic Approach for Cardiometabolic Disease Management During COVID-19: The CAPISCO International Expert Panel.

Front Cardiovasc Med. 2021 Dec 15;8:787761. doi: 10.3389/fcvm.2021.787761. eCollection 2021.

Cardiometabolic Alterations in the Interplay of COVID-19 and Diabetes: Current Knowledge and Future Avenues.

Int J Mol Sci. 2021 Nov 15;22(22):12311. doi: 10.3390/ijms222212311.

Use of Novel Antidiabetic Agents in Patients with Type 2 Diabetes and COVID-19: A Critical Review.

Diabetes Ther. 2021 Dec;12(12):3037-3054. doi: 10.1007/s13300-021-01170-3. Epub 2021 Oct 26.

The role of GLP-1 receptor agonists during COVID-19 pandemia: a hypothetical molecular mechanism.

Expert Opin Drug Saf. 2021 Nov;20(11):1309-1315. doi: 10.1080/14740338.2021.1970744. Epub 2021 Aug 25.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

The Importance of a Novel Syndemic Approach for Cardiometabolic Diseases.

作者信息

Rizzo Manfredi

机构信息

School of Medicine, Promise Department, University of Palermo, Palermo, Italy.

出版信息

Curr Med Chem. 2024;31(18):2483-2485. doi: 10.2174/0929867331666230918114009.

DOI:10.2174/0929867331666230918114009

PMID:37723636

Abstract

摘要

相似文献

The Importance of a Novel Syndemic Approach for Cardiometabolic Diseases.

Curr Med Chem. 2024;31(18):2483-2485. doi: 10.2174/0929867331666230918114009.

Editorial: Molecular biomarkers of cardiometabolic disease.

Front Endocrinol (Lausanne). 2024 Aug 12;15:1471571. doi: 10.3389/fendo.2024.1471571. eCollection 2024.

Emerging therapeutic potential of glycine in cardiometabolic diseases: dual benefits in lipid and glucose metabolism.

Curr Opin Lipidol. 2018 Oct;29(5):428-432. doi: 10.1097/MOL.0000000000000543.

New lipid and lipoprotein targets for the treatment of cardiometabolic diseases.

J Lipid Res. 2012 Sep;53(9):1719-21. doi: 10.1194/jlr.E030205. Epub 2012 Jul 5.

Targeting Apelinergic System in Cardiometabolic Disease.

Curr Drug Targets. 2017;18(15):1785-1791. doi: 10.2174/1389450117666160613105152.

Targeting Interferon Regulatory Factor for Cardiometabolic Diseases: Opportunities and Challenges.

Curr Drug Targets. 2017;18(15):1754-1778. doi: 10.2174/1389450116666150804110412.

Metabolic syndrome and cardiometabolic risk in PCOS.

Curr Diab Rep. 2007 Feb;7(1):66-73. doi: 10.1007/s11892-007-0012-8.

Adrenomedullin 2/intermedin: a putative drug candidate for treatment of cardiometabolic diseases.

Br J Pharmacol. 2018 Apr;175(8):1230-1240. doi: 10.1111/bph.13814. Epub 2017 May 16.

Promoting a Syndemic Approach for Cardiometabolic Disease Management During COVID-19: The CAPISCO International Expert Panel.

Front Cardiovasc Med. 2021 Dec 15;8:787761. doi: 10.3389/fcvm.2021.787761. eCollection 2021.

Insight from mitochondrial functions and proteomics to understand cardiometabolic disorders in survivors of acute lymphoblastic leukemia.

Metabolism. 2018 Aug;85:151-160. doi: 10.1016/j.metabol.2018.03.011. Epub 2018 Mar 18.

本文引用的文献

Exp Clin Endocrinol Diabetes. 2023 May;131(5):260-267. doi: 10.1055/a-2019-1111. Epub 2023 Jan 24.

Centering Patient Voices Through Community Engagement in Cardiovascular Research.

Circulation. 2023 Jan 10;147(2):105-107. doi: 10.1161/CIRCULATIONAHA.122.061112. Epub 2023 Jan 9.

Post-COVID syndrome, inflammation, and diabetes.

J Diabetes Complications. 2022 Nov;36(11):108336. doi: 10.1016/j.jdiacomp.2022.108336. Epub 2022 Oct 6.

Molecular and pro-inflammatory aspects of COVID-19: The impact on cardiometabolic health.

Biochim Biophys Acta Mol Basis Dis. 2022 Dec 1;1868(12):166559. doi: 10.1016/j.bbadis.2022.166559. Epub 2022 Sep 26.

The Dual Pandemics of COVID-19 and Obesity: Bidirectional Impact.

Diabetes Ther. 2022 Oct;13(10):1723-1736. doi: 10.1007/s13300-022-01311-2. Epub 2022 Aug 27.

Association between use of novel glucose-lowering drugs and COVID-19 hospitalization and death in patients with type 2 diabetes: a nationwide registry analysis.

Eur Heart J Cardiovasc Pharmacother. 2022 Dec 15;9(1):10-17. doi: 10.1093/ehjcvp/pvac044.

Promoting a Syndemic Approach for Cardiometabolic Disease Management During COVID-19: The CAPISCO International Expert Panel.

Front Cardiovasc Med. 2021 Dec 15;8:787761. doi: 10.3389/fcvm.2021.787761. eCollection 2021.

Cardiometabolic Alterations in the Interplay of COVID-19 and Diabetes: Current Knowledge and Future Avenues.

Int J Mol Sci. 2021 Nov 15;22(22):12311. doi: 10.3390/ijms222212311.

Use of Novel Antidiabetic Agents in Patients with Type 2 Diabetes and COVID-19: A Critical Review.

Diabetes Ther. 2021 Dec;12(12):3037-3054. doi: 10.1007/s13300-021-01170-3. Epub 2021 Oct 26.

The role of GLP-1 receptor agonists during COVID-19 pandemia: a hypothetical molecular mechanism.

Expert Opin Drug Saf. 2021 Nov;20(11):1309-1315. doi: 10.1080/14740338.2021.1970744. Epub 2021 Aug 25.